Navigation Links
Does food act physiologically like a 'drug of choice' for some?
Date:7/19/2011

Variety is considered the "spice of life," but does today's unprecedented level of dietary variety help explain skyrocketing rates of obesity? Some researchers think it might.

According to ASN Spokesperson Shelley McGuire, PhD: "We've known for years that foods- even eating, itself- can trigger release of various brain chemicals, some of which are also involved in what happens with drug addiction and withdrawal. And, as can happen with substance abusers, tolerance or "habituation" can occur, meaning that repeated use (in this case, exposure to a food) is sometimes accompanied by a lack of response (in this case, disinterest in the food). The results of the study by Epstein and colleagues provides a very interesting new piece to the obesity puzzle by suggesting that meal monotony may actually lead to reduced calorie consumption. The trick will be balancing this concept with the importance of variety to good nutrition."

Studies have shown that many people become disinterested in a particular food when they are repeatedly exposed to it. This response, called habituation, can decrease caloric intake in the short-run. Conversely, when presented with a variety of foods, caloric intake can increase. The "food addiction hypothesis" purports that some people may overeat because they are insensitive to the normal habituation response and thus need even more exposure to a food to trigger a disinterest. However, there has been no rigorous research investigating whether healthy-weight and overweight individuals have different habituation responses, and little is known about what patterns of food exposure are most powerful in triggering habituation. To help close these research gaps, researchers studied long-term habituation in obese and nonobese women. Their results, and an accompanying editorial by Nicole Avena and Mark Gold, are published in the August 2011 issue of The American Journal of Clinical Nutrition.

Sixteen nonobese [BMI (in kg/m2) < 30] and 16 obese (BMI  30) women were randomly assigned to 1 of 2 groups: the "weekly group" participated in weekly experimental food exposure sessions for 5 wk, whereas the "daily group" were studied daily for 5 consecutive days. During each 28-min experimental session, subjects were asked to complete a variety of tasks after which they were "rewarded" by being given a 125-kcal portion of macaroni and cheese. Participants could work for as much food as they wanted. The researchers then evaluated total energy intake.

Whereas weekly food exposure increased total caloric intake by approximately 30 kcal/d, daily exposure decreased energy consumption by ~100 kcal/d. This supports long-term habituation in terms of caloric intake. Very few differences were found between how obese and nonobese individuals responded.

The authors concluded that reducing variety in food choices may represent an important strategy for those trying to lose weight. Moreover, having a person even remember that they have eaten a certain food recently may be effective in this regard. In their accompanying editorial, Avena and Gold compare physiologic components of the food addiction hypothesis to the body's addictive responses to drugs. They also ponder whether school-lunch planners and public health officials should note that diversity in the menu is not necessarily a virtue" but might instead "be associated with promoting excess food intake and increased body mass index." Provocative food for thought.


'/>"/>

Contact: Suzanne Price
sprice@nutrition.org
American Society for Nutrition
Source:Eurekalert

Related biology news :

1. Penn vet researchers show lymphoma drug shrinks dog tumors, could lead to human treatment
2. Research provides insight into new drug resistance in hospital microbes
3. Needle-in-a-haystack search for new drugs for brain diseases
4. GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
5. Drug designer
6. Drug shield helps target antibiotic resistant bacteria
7. GEN point of view article questions reported costs of drug R&D
8. Unique gel capsule structure enables co-delivery of different types of drugs
9. UBC researchers invent new drug delivery device to treat diabetes-related vision loss
10. Will new drugs block hepatitis C virus in its tracks?
11. Premature aging caused by some HIV drugs, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2017)... 17, 2017 NXT-ID, Inc. (NASDAQ: NXTD ... filing of its 2016 Annual Report on Form 10-K on Thursday ... ... available in the Investor Relations section of the Company,s website at ... website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... At its ... announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of ... been selected for membership in ARCS Alumni Hall of Fame . ASTER ...
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofilerâ„¢ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
Breaking Biology Technology: